Please read the guidelines in full before submitting your manuscript.
Manuscripts not conforming to these guidelines may be returned.
This Journal is a member of the Committee on Publication Ethics.
The Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Sage is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the author responsibilities section on the Sage Journal Author Gateway.
We also encourage you to familiarize yourself with our Editorial Policies and our Publication Ethics Policies.
Sage Publishing disseminates high-quality research and engaged scholarship globally, and we are committed to diversity and inclusion in publishing. We encourage submissions and peer review from a diverse range of authors and reviewers from across all countries and backgrounds. Read our diversity, equity, and inclusion pledge.
Please read the guidelines below then submit your manuscript here.
Access: Subscription
APC: See article processing charge information below
Accepts preprints? Yes
Identity transparency: Single anonymized
Aims and Scope
Toxicologic Pathology is dedicated to the promotion of human, animal, and environmental health through the dissemination of knowledge, techniques, and guidelines to enhance the understanding and practice of toxicologic pathology. It is the official journal of the Society of Toxicologic Pathology, the British Society of Toxicological Pathology and the European Society of Toxicologic Pathology.
Relevant topics include:
Toxicologic Pathology does not generally accept manuscripts related to human diagnostics or clinical trials (unless relevant to translational understanding of toxicologic pathology), uncharacterized botanicals or their extracts, studies which endorse or promote chemoprevention, or studies which assess therapeutic intervention of toxicity.
Manuscript Fees. In order to offset increasing publication costs, the Society has established a standard charge of $250.00 for each accepted manuscript. Payment should be made to Sage Publications by major credit card at the time of manuscript acceptance through the Sage Journals Submission site.
Color Figure Charges. There is no charge to authors for color images produced in the journal; however, we ask that authors only provide color artwork that is necessary and appropriate. Our referees will be asked to ensure that only those figures deemed absolutely necessary for the clarity of the manuscript will be allowed and any surplus to requirements will be removed.
All articles are made free to read one year after publication.
Optional open access publishing is available for a fee via the Sage Choice program, and Open Access agreements, where authors can publish open access either discounted or free of charge depending on the agreement with Sage. Find out if your institution is participating by visiting Open Access Agreements at Sage. Open Access agreement eligibility is determined by the corresponding author’s affiliation matching an agreement at acceptance. For more information on Open Access publishing options at Sage please visit Sage Open Access.
For information on funding body compliance, and depositing your article in repositories, please visit Sage’s Author Archiving and Re-Use Guidelines and Publishing Policies.
Your article must be within the scope of the journal and be of sufficient quality. If not, it will not be reviewed. Please read the journal’s Aims and Scope to see if your article is appropriate.
The manuscript must be your original work, you must have the rights to the work, and you must have obtained and be able to supply all necessary permissions for the reproduction of any copyright works not owned by you, including figures, illustrations, tables, lengthy quotations, or other material previously published elsewhere.
Please visit the Sage Journal Author Gateway for guidance on producing visual and/or video abstracts.
Toxicologic Pathology publishes the following article types: Original research, brief communications (including case series and case reports), reviews and mini-reviews, practice and policy manuscripts, meeting reports, editorial and opinion pieces, and book reviews.
Information provided on details for the various publication categories in Toxicologic Pathology can be found at: Boyle MH, Bennet B, Colman K, et al. Publication Categories in Toxicologic Pathology. Toxicologic Pathology. 2021;49(5):1042-1047. doi:10.1177/0192623321992305
There are no manuscript word counts or limits. Limitations only apply to abstract length.
Original Research
Original research manuscripts present data from hypothesis-driven research performed in a rigorous and detailed fashion, in which researchers perform, analyze, and interpret their own data. Information included should be relevant to the practice or interpretation of toxicologic pathology and should add new information to the literature.
Brief Communications and Case Reports
Brief Communications may describe any topic relevant to the practice of toxicologic pathology that does not warrant a full-length paper. This may include short investigative research reports, case series, or case reports.
Review Articles
Review articles summarize and critically evaluate existing knowledge on specific topics relevant to the practice of toxicologic pathology and its interpretation. These manuscripts provide an overview of the current state of knowledge and may describe identify gaps in our understanding of the subject, without presenting new experimental data.
Mini Reviews
Mini Reviews may describe any topic relevant to the practice of toxicologic pathology that does not warrant a full-length paper. Mini reviews are summaries of recent insights or advances in areas within the scope of the journal and are usually commissioned from experts in a particular specialty area. Authors should provide a balance overview of the field and not focus on their own work or the work of close colleagues.
Meeting Reports:
Meeting report proposals should be pre-approved by the Editor-in-Chief of Toxicologic Pathology prior to submission. Meeting reports should be submitted within 1 year of the meeting and highlight major presentations, emerging trends, and future directions shared during the session(s).
Letters to the Editor/Book Reviews/Other Manuscript Types
Sample copies of Letters to the Editor and Books Reviews can be found on the Instructions and Forms Page of Manuscript Central.
Authors may submit one Letter to the Editor in response to a recent published manuscript. The author of the published article will be given an opportunity to prepare a rebuttal in the form of a Letter to Editor. Authors may to submit only one Letter to the Editor relating to a specific published paper.
Information on preparing other manuscript types should be directed to the Editor-in-Chief or the Managing Editor at the Editorial Office.
The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.
If your research involves animals, you will be asked to confirm that you have carefully read and adhered to the ARRIVE guidelines.
The preferred format for your manuscript is Word. You do not need to follow a template, but please ensure your heading levels are clear, and the sections clearly defined.
Manuscripts should be double-spaced throughout (including references, footnotes, tables, and figure legends).
Citations and Reference formatting:
The journal follows the AMA Manual of Style. View the AMA Manual of Style to ensure your manuscript conforms.
Every in-text citation must have a corresponding citation in the reference list and vice versa. Corresponding citations must have identical spelling and year. Authors should update any references to preprints when a peer reviewed version is made available, to cite the published research. Citations to preprints are otherwise discouraged.
Footnotes should be used sparingly, indicated by Arabic numerals superscripted to the authors, text, or titles. Footnotes should be typed sequentially on a separate page and can include disclaimers, the source of grant support, and address for offprint requests.
A Cover letter saved in Microsoft Word format (.doc) or rich text format (.rtf) may be uploaded to the Sage Journals Submission site.
Your article title, keywords, and abstract all contribute to its position in search engine results, directly affecting the number of people who see your work. For details of what you can do to influence this, visit How to help readers find your article online.
Your manuscript’s title should be concise, descriptive, unambiguous, accurate, and reflect the precise contents of the manuscript. A descriptive title that includes the topic of the manuscript makes an article more findable in the major indexing services.
The Abstract should be one paragraph consisting of a 150-to-200-word concise description of the objectives, methods, findings, and significance of the research. Brief Communication and Mini-Review abstracts are limited to 150 words.
If your research includes clinical trials, the trial registry name and URL, and registration number must be included at the end of the abstract. Submissions that do not meet this requirement will not be considered. For clinical trials, the trial registry name and URL, and registration number must be included at the end of the abstract.
This journal accepts graphical abstracts.
The Keywords Page facilitates indexing and retrieval services. The system will require you to enter a minimum of 3 and a maximum of 7 keywords.
The Introduction should contain brief background information and a clear statement of purpose and significance of the research being reported.
The Materials and Methods should provide a brief description of the experimental design and detailed methods for experiments conducted. Please utilize Arrive Guidelines when building your methods section. Methods and techniques that are well established should be referenced only. The description of the methods should allow reproducibility by other investigators. In reports covering in vivo experimentation, a description of the anesthesia or other procedures to avoid unnecessary pain or suffering should be included. Authors must state their compliance regarding rights of subjects in human experimentation or humane treatment and care of animals in research. This means that a statement specifically stating that the study was approved by an Institutional Care and Use Committee (IACUC) or equivalent ethical review committee.
The Results section should concisely present findings from experiments described in Material and Methods section. Tables and figures should illustrate important points.
Discussion should concentrate on the discussion of the findings presented and, in context with other relevant published work, include the major points that add to the significance of the work. Extensive literature reviews or highly speculative discussion are discouraged.
Additional information on submission of Brief Communications (Including Case Series/Case Reports)
These succinct manuscripts should have the same structure as full-length Original Research Articles but in much shorter form. Such brief reports will be prepared using the same formatting instructions as Original Research Articles, except that section headings will be used only for the Abstract, Acknowledgements, and References.
Brief Communications generally do not exceed three printed pages (usually six manuscript pages), including illustrations, tables, and references. Abstracts for Brief Communications should not exceed 150 words and the number of citations should be limited to 15.
Additional information on submissions of Mini Reviews
These succinct manuscripts should have the same structure as full-length Original Research Articles but in much shorter form. Mini reviews should be prepared using the same formatting instructions as Original Research Articles, except that section headings will be used only for the Abstract, Acknowledgements, and References.
Mini Reviews generally do not exceed seven double-spaced, typed pages. In addition to the text, there may be 1-2 figures and 1-2 tables. Abstracts should not exceed 150 words and the number of citations should be limited to 15.
Figure Legends
Figure legends may be uploaded to the Sage Journals Submission site when the figures are uploaded, but they should always be included at the end of the manuscript. Figure legends should be complete and allow the reader to understand the figure without reading the text. Stains used or special techniques should be indicated. Scale bars and magnifications are not required and not preferred due to common inaccuracies.
For guidance on the preparation of illustrations, pictures, and graphs in electronic format, please read Sage’s artwork guidelines.
Please do not submit figures in PowerPoint, PDF or Word format. Each figure must be submitted as a separate file in the appropriate format specified below.
Specific directions for photomicrographs, scans, or gray-scale images:
Specific directions for line art, illustrations or graphs:
Specific directions for scanned images:
Figure File Limits
No more than 20 individual figure files may be uploaded into the Sage Journals Submission site (this includes supplemental figure files). If you have more than 20 individual figure files, please contact the Editorial Office at TPX@toxpath.org to receive instructions on how to submit your figures for review.
Figure Legends
Figure legends may be uploaded to the Sage Journals Submission site when the figures are uploaded, but they should always be included at the end of the manuscript. Figure legends should be complete and allow the reader to understand the figure without reading the text. Stains used or special techniques should be indicated. Scale bars and magnifications are not required and not preferred due to common inaccuracies.
Image Magnifications
In the figure legend, there is no requirement to indicate image size. But if an image size is used, only state "original objective 2X", "original objective 4X", "original objective 10X", etc. There should be no calculations for camera adapter lens, camera eyepiece lens, alteration of a photomicrograph with computer software, etc. If cell or object size needs to be accurate, then a black bar may be used in the lower right-hand corner with an indication of micron size in the legend. If scanned images are used, please use “original scan 2X”, etc.
Supplemental Figures and Tables
Supplemental figures and tables can be included in the online version of published manuscripts. Please choose the file type “Supplementary Material for Review and Publication” when uploading your figure and table files.
Preparing Supplemental Figures
Please note that supplemental files, including figures will not be reviewed or edited by the illustrations editor or the copyeditor. Authors are responsible for ensuring all information submitted is accurate and correct and are responsible for any errors or formatting problems. These files will also not be professionally typeset so it is important that you submit them in the final format as they will be published online exactly how they are submitted.
Tables may be submitted in Word or Excel (for large data tables) file format.
Legends for supplemental figures and tables should be uploaded as a separate Word document and marked as “supplemental” file. Do not include the legends for supplemental tables and figures in the main text of your manuscript.
Figure Policy
Manuscript figures that are not submitted in accordance with the journal’s Instructions for Figures will be returned to the author. Manuscripts will not be sent out for peer review until the figures are prepared correctly. The journal does not offer figure preparation services for authors. Authors may contact the Editorial Office with questions or requests for additional information on how to prepare their figures, however, authors should not contact the journal with requests to prepare their figures for them before submission. It is up to the author to prepare their own figures for submission. There will be no exceptions to this policy.
Once a manuscript has been accepted to the journal and the figures have been approved by the Illustrations Editor, the final figures will then be prepared for publication purposes. This may include minor adjustments to the images such as white balancing, formatting of labeling and special characters, and creating the composite figures from the individual (approved) files provided by the author.
For questions or additional information on figure preparation, please contact: Beth Mahler, Illustrations Editor, Experimental Pathology Laboratories (mahler1@nih.gov).
Figures Reproduced or Adapted from Other Sources
It is preferable to use original figures rather than those already published. When use of a previously published illustration, photograph, or other figure is determined necessary, written permission to reproduce it must be obtained from the copyright holder (usually the publisher). The original source should be acknowledged in the legend. If the original source in which the illustration has been published is included in the reference list, the reference may be cited in the legend, with the citation number for the reference corresponding to its first appearance in the text, tables, or figures.
Example: Reprinted with permission from the American Academy of Pediatrics.5
Figures supplied in color will appear in color online and in the print issue. There is no charge for reproducing figures in color in the printed version.
Please ensure that you have obtained any necessary permission from copyright holders for reproducing any illustrations, tables, figures, or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please see the Frequently Asked Questions page on the Sage Journal Author Gateway.
If you are including an Acknowledgements section, this will be published at the end of your article. The Acknowledgments section should include all contributors who do not meet the criteria for authorship. Per ICMJE recommendations, it is best practice to obtain consent from non-author contributors who you are acknowledging in your manuscript.
Writing assistance and third party submissions: if you have received any writing or editing assistance from a third-party, for example a specialist communications company, this must be clearly stated in the Acknowledgements section and in the covering letter. Please see the Sage Author Gateway for what information to include in your Acknowledgements section. If your submission is being made on your behalf by someone who is not listed as an author, for example the third-party who provided writing/editing assistance, you must state this in the Acknowledgements and also in your covering letter. Please note that the journal editor reserves the right to not consider submissions made by a third party rather than by the author/s themselves.
You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.
Please include a section with the heading ‘Statements and Declarations’ at the end of your submitted article, after the Acknowledgements section [and Author Contributions section if applicable] including each of the sub-headings listed below. If a declaration is not applicable to your submission, you must still include the heading and state ‘Not applicable’ underneath. Please note that you may be asked to justify why a declaration was not applicable to your submission by the Editorial Office.
Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. You can find information on what to say in your ethical statements as well as example statements on our Publication ethics and research integrity policies page.
All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved the study, or waived the requirement for approval, providing the full name and institution of the review committee in addition to the approval number. If applicable, please also include this information in the Methods section of your manuscript.
Please include any participant consent information under this heading and state whether informed consent to participate was written or verbal. If the requirement for informed consent to participate has been waived by the relevant Ethics Committee or Institutional Review Board (i.e. where it has been deemed that consent would be impossible or impracticable to obtain), please state this. If this is not applicable to your manuscript, please state ‘Not applicable’ in this section. More information and example statements can be found on our Publication ethics and research integrity policies page.
Submissions containing any data from an individual person (including individual details, images or videos) must include a statement confirming that informed consent for publication was provided by the participant(s) or a legally authorized representative. Non-essential identifying details should be omitted. Please do not submit the participant’s actual written informed consent with your article, as this in itself breaches the patient’s confidentiality. The Journal requests that you confirm to us, in writing, that you have obtained written informed consent to publish but the written consent itself should be held by the authors/investigators themselves, for example in a patient’s hospital record. The confirmatory letter may be uploaded with your submission as a separate file in addition to the statement confirming that consent to publish was obtained within the manuscript text. If this is not applicable to your manuscript, please state ‘Not applicable’ in this section.
The journal requires a declaration of conflicting interests from all authors so that a statement can be included in your article. For guidance on conflict of interest statements, see our policy on conflicting interest declarations and the ICMJE recommendations.
If no conflict exists, your statement should read: ‘The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article’.
All articles need to include a funding statement, under a separate heading, even if you did not receive funding. You’ll find guidance and examples on our Funding page.
The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages.
Subject to appropriate ethical and legal considerations, authors are encouraged to:
The journal follows the AMA Manual of Style. View the AMA Manual of Style to ensure your manuscript conforms.
Every in-text citation must have a corresponding citation in the reference list and vice versa. Corresponding citations must have identical spelling and year.
Authors should update any references to preprints when a peer reviewed version is made available, to cite the published research. Citations to preprints are otherwise discouraged.
IMPORTANT NOTE: If using Endnote, EndNote provides a number of terms list to make sure that the journal names in your bibliography abbreviated (our journal does not use full names). More information on how to make sure your Endnote software will generated abbreviated journal titles can be found at the following link: https://support.clarivate.com/Endnote/s/article/EndNote-Generate-full-or-abbreviated-journal-names?language=en_US
Cited works are alphabetized in the reference list and will appear in order of initial appearance in the text.
This Journal can host additional materials online (e.g. datasets, podcasts, videos, images etc.) alongside the full text of the article. Your supplemental material must be one of our accepted file types. For that list and more information please refer to our guidelines on submitting supplemental files.
Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using Sage Author Services. Visit Sage Author Services for further information.
As part of the submission process you will need to confirm that this is your original work, that you have the rights in the work, that this is for first publication in this Journal, that it is not being considered for/has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.
Please see our guidelines on prior publication and note that the journal may accept submissions of manuscripts that have been posted on preprint servers.
The journal will consider submissions of manuscripts that have been posted on preprint servers.
Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission.
Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed.
Submit your manuscript online via Sage Track.
IMPORTANT: Please check whether you already have an account in Sage Track before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created. For further guidance on submitting your manuscript online please visit ScholarOne Online Help.
Manuscripts should only be submitted with the consent of all contributing authors. The individual responsible for submitting the manuscript should carefully check that all those whose work contributed to the manuscript are listed as authors.
Ensure you upload all relevant manuscript files, including any additional supplemental files (including reporting guidelines where relevant).
Please view our authorship policies, which includes information on criteria for authorship, who should be the corresponding author and more.
Please note that AI chatbots, for example ChatGPT, should not be listed as authors. For more information see the policy on Use of ChatGPT and generative AI tools.
The following summary describes the peer review process for this journal:
Identity transparency: Single-anonymized
Reviewer interacts with: Editor
Review information published: None
Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejected without peer review at this point if they are out of scope for the journal or otherwise unsuitable.
After passing the initial evaluation, your manuscript will then be peer reviewed. You can log in at any time to check the status of your manuscript. We will notify you when a decision has been reached.
Toxicologic Pathology operates a conventional single-anonymized reviewing policy in which the reviewer’s name is always concealed from the submitting author.
The journal’s policy is to have manuscripts reviewed by three expert reviewers. Reviewers leave comments to the author and submit recommendations to the Editors who then make the final decisions.
Reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Our policy is that reviewers should not be assigned to a paper if:
Toxicologic Pathology is committed to delivering high quality, fast peer-review for your paper, and as such has partnered with Web of Science (formerly Publons). Web of Science (WoS) is a third-party service that seeks to track, verify and give credit for peer review. Reviewers for Toxicologic Pathology can opt in to WoS in order to claim their reviews or have them automatically verified and added to their reviewer profile. Reviewers claiming credit for their review will be associated with the relevant journal, but the article name, reviewer’s decision and the content of their review is not published on the site. For more information visit the WoS website.
To ensure the integrity of the peer review process we assign reviewers and cannot accept author recommendations.
All manuscripts are reviewed as rapidly as possible, while maintaining rigor. Reviewers make comments to the author and recommendations to the Editor who then makes the final decision on all manuscripts, including those appearing in a special issue or special collection. The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the Journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor/Board member will have no involvement in the decision-making process.
The journal has an Editorial Board who serve the journal as external peer reviewers. Each member of the Editorial Board are active researchers in the field and selected based on strict criteria, ensuring they possess the necessary expertise and experience. The Editor(s) may use one Editorial Board Member as a reviewer for each manuscript, and will then reach beyond this pool to include additional reviewers to meet the required number before a decision can be made. This ensures a comprehensive and robust peer review process, aligning with our commitment to publish the most credible and valid research. Care is taken not to invite any Editorial Board Member that has any potential conflict of interest with any author of the paper.
Editorial Board Member Disclosure
In addition to standard conflict of interest disclosures, authors who are members of the Editorial Board of Toxicologic Pathology must explicitly disclose this role when submitting a manuscript to the journal. Transparency regarding editorial affiliations helps maintain trust in the peer review process and supports the integrity of the scientific record.
Editorial Board members who submit manuscripts must include a statement confirming that they had no involvement in the peer review or editorial decision-making process for their own submission.
This disclosure should be included as part of the standard Declaration of Conflicting Interests statement at the end of the manuscript.
Examples:
As a COPE member we engage with multiple forms of post-publication discussion in line with wider guidance from Sage: Commentaries, Critiques and Responses.
You can view our complaints and appeals policy here.
Read Sage's complete peer review policy.
The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.
Before publication, we require the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. Sage’s Journal Contributor’s Publishing Agreement is an exclusive license agreement which means that the author retains copyright in the work but grants Sage the sole and exclusive right and license to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than Sage. In this case copyright in the work will be assigned from the author to the society. For more information please visit the Sage Journal Author Gateway.
If your manuscript was posted on a preprint server prior to acceptance, you must include a link in your preprint to the final published version of your published article.
Your Sage Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be made available to the corresponding author via our editing portal, Sage Edit, or by email, and should be returned promptly to avoid delaying publication. Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence, and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. This is the final opportunity to make changes to your manuscript. Further corrections will not be possible after publication. Changes to the author list are not permitted at this stage.
OnlineFirst publication: This enables us to publish final articles online immediately, without waiting for assignment to a future issue of the Journal. This usually significantly reduces publication lead time. Visit the Sage Journals help page for more details, including how to cite OnlineFirst articles.
Access to your published article: We provide you with online access to your published article. The online access link is provided to the corresponding author for sharing with their co-authors.
Publication is not the end of the process. Between us, we can ensure that your article is found, read, downloaded and cited as widely as possible. Many of the most effective tactics are those you can do quickly and easily to your network of contacts and peers. Visit the Promote Your Article page on the Sage Journal Author Gateway for numerous resources to help you promote your work.
The Sage Journal Author Gateway has some general advice on how to get published, plus links to further resources. Sage Author Services also offers authors a variety of ways to improve and enhance your article including English language editing, plagiarism detection, and video abstract and infographic preparation.
If you have any questions about publishing with Sage, please visit the Sage Journals Solutions Portal.
You can view our complaints and appeals procedure.
Any correspondence, queries, or additional requests for information on the manuscript submission process should be sent to the Toxicologic Pathology editorial office as follows:
Kevin Keane DVM, PhD, FIATP
Editor-in-Chief
Blueprint Medicine
Cambridge, MA
Email: TPXeditor@toxpath.org
Tom Green
Managing Editor
J&J Editorial Email: tpx@toxpath.org
Beth Mahler
Illustrations Editor
Experimental Pathology Laboratories
Email: mahler1@nih.gov